CTR Investments & Consulting to Add DataSafe to Its Core Suite of Products

The Company Announces the Agreement to License DataSafe


FAIRFAX, Va., Jan. 26, 2006 (PRIMEZONE) -- CTR Investments & Consulting, Inc. (Pink Sheets:CIVX) has agreed to license the DataSafe Solution Set from Phase2e.

As the Company continues to complete its analysis and review of the existing company product sets it has decided to complete the DataSafe license portion of the Phase2e merger and exercise its option to not acquire the remainder of the company portion of Phase2e.

The DataSafe Solution Set provides the controls needed to convert standard electronic data into legally bound electronic records. The SolutionSet provides modules to capture electronic records, wrap them with a security seal, and then control access assuring its authenticity and legal status. For example a contract can now be stored electronically and have the same legal status as if it were on paper.

Jerry Janik, CEO states, "Both CTR and Phase2e continue to have a good working relationship this licensing agreement is beneficial for both companies. DataSafe is a valuable addition to the new line of products that the Company will be unveiling in the coming weeks."

About CTR Investments & Consulting, Inc.

CTR Investments and Consulting, Inc. provides a family of information technology services and products used by customers in the financial, government and health care sectors. CTR's specialization is in identity information and data assurance, security and encryption technologies. CTR's major offerings are: BioKey ID identity card systems; DataSafe products/services set for capturing and securing electronic documents and information; and a line of Biometric Facial Recognition solutions.

Except for historical information, all other information provided in this news release consists of "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1935. These "forward-looking statements" are subject to risks and uncertainties, which could cause actual results to differ materially from those projected, anticipated or implied. The most significant of these risks and uncertainties are discussed and identified in CTR Investment & Consulting, Inc.'s public filings made with the Securities and Exchange Commission, and include (but are not limited to) a possible inability to raise adequate capital to execute proposed strategies, changes in overall strategy due to economic, regulatory, governmental and/or market conditions, the costs and difficulties related to integration of potentially acquired businesses, potential changes in customer and supplier relationships of potentially acquired firms, changes in governmental regulations, changes in management, and changes in financial markets.


            

Contact Data